Ocular Surface Disease

A recent study reveals significant ocular complications from monkeypox, highlighting the need for enhanced eye health strategies in affected regions.

Sezen Karakus, MD, highlights options including compounded cyclosporine, autologous serum drops, recombinant human nerve growth factor, and newer topical agents to manage refractory or neurotrophic dry eye.

Alternative management may avoid current concerns found with antibiotics.

Tips for optimizing surgical techniques to reduce recurrence and enhance outcomes.

The trial is being discontinued based on the recommendation from an Independent Data Monitoring Committee (IDMC) to stop the trials for “futility."

A phase IV study in China found that 22 of 26 patients achieved complete healing of a persistent corneal epithelial defect or corneal ulcer after 8 weeks.

A study from a tertiary eye hospital suggests that effective keratitis management may have the potential to restore vision.

Under the terms of the agreement Iolyx Therapeutics has granted Théa exclusive worldwide development and commercialization rights, excluding Asia, to ILYX-002 for the treatment of ocular surface diseases.

Real-world insights emphasize identifying underlying causes to tailor treatment.

In addition to Thompson joining the board of directors, EyeCool also announced the members joining its newly formed medical advisory board (MAB).

Hidden signs of systemic disease, including heart attacks, may first reveal themselves through visual symptoms or subtle patient cues in the exam chair.

Timely diagnosis and personalized treatment are key to improving visual outcomes.

This population requires careful attention from diagnosis through the entire postoperative process.

Italian investigators reported that ocular surface conditions such as dry eye disease are key factors in perioperative outcomes, even when patients achieve 20/20 vision.

This year was brimming with advancements in eye care.

Common glaucoma treatments may worsen ocular surface disease and meibomian gland dysfunction, leading to discomfort, redness, and even poor treatment compliance.

The team conducted a cross-sectional study from December 2016 to March 2024 in patients with acute infectious conjunctivitis

All patients included in the study had been referred to Ocular Oncology Service of the Federal University of São Paulo with the suspicion of ocular metastasis.

The module encompasses real world data on more than 250,000 de-identified patients and provides information on extracting diagnoses from clinical notes in electronic health records.

Pterygium is an ocular disease commonly referred to as “surfer’s eye,” which can result from exposure to high levels of UV radiation.